Search

Author/Creator Swain, Sandra M

1. Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials. Issue 3 (March 2022)

Authors:
Bradley, Rosie; Braybrooke, Jeremy; Gray, Richard; Hills, Robert K; Liu, Zulian; Pan, Hongchao; Peto, Richard; Dodwell, David; McGale, Paul; Taylor, Carolyn; Francis, Prudence A; Gnant, Michael; Perrone, Francesco; Regan, Meredith M; Berry, Richard; Boddington, Clare; Clarke, Mike; Davies, Christ...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 3(2022)
Page Start:
382
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial. Issue 9 (September 2015)

Authors:
Bear, Harry D; Tang, Gong; Rastogi, Priya; Geyer, Charles E; Liu, Qing; Robidoux, André; Baez-Diaz, Luis; Brufsky, Adam M; Mehta, Rita S; Fehrenbacher, Louis; Young, James A; Senecal, Francis M; Gaur, Rakesh; Margolese, Richard G; Adams, Paul T; Gross, Howard M; Costantino, Joseph P; Paik, Soonmy...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 9(2015:Sep.)
Page Start:
1037
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial. Issue 9 (September 2015)

Authors:
Bear, Harry D; Tang, Gong; Rastogi, Priya; Geyer, Charles E; Liu, Qing; Robidoux, André; Baez-Diaz, Luis; Brufsky, Adam M; Mehta, Rita S; Fehrenbacher, Louis; Young, James A; Senecal, Francis M; Gaur, Rakesh; Margolese, Richard G; Adams, Paul T; Gross, Howard M; Costantino, Joseph P; Paik, Soonmy...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 9(2015:Sep.)
Page Start:
1037
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study. Issue 4 (April 2020)

Authors:
Swain, Sandra M; Miles, David; Kim, Sung-Bae; Im, Young-Hyuck; Im, Seock-Ah; Semiglazov, Vladimir; Ciruelos, Eva; Schneeweiss, Andreas; Loi, Sherene; Monturus, Estefanía; Clark, Emma; Knott, Adam; Restuccia, Eleonora; Benyunes, Mark C; Cortés, Javier
Journal:
Lancet oncology
Issue:
Volume 21:Issue 4(2020)
Page Start:
519
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer. (19th March 2019)

Authors:
Kim, Rim S; Song, Nan; Gavin, Patrick G; Salgado, Roberto; Bandos, Hanna; Kos, Zuzana; Floris, Giuseppe; Eynden, Gert G G M Van den; Badve, Sunil; Demaria, Sandra; Rastogi, Priya; Fehrenbacher, Louis; Mamounas, Eleftherios P; Swain, Sandra M; Wickerham, D Lawrence; Costantino, Joseph P; Paik, Soo...
Journal:
Journal of the National Cancer Institute
Issue:
Volume 111:Number 8(2019)
Page Start:
867
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study. Issue 1 (January 2017)

Authors:
Luen, Stephen J; Salgado, Roberto; Fox, Stephen; Savas, Peter; Eng-Wong, Jennifer; Clark, Emma; Kiermaier, Astrid; Swain, Sandra M; Baselga, Jose; Michiels, Stefan; Loi, Sherene
Journal:
Lancet oncology
Issue:
Volume 18:Issue 1(2017:Jan.)
Page Start:
52
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 1 (January 2019)

Authors:
Mamounas, Eleftherios P; Bandos, Hanna; Lembersky, Barry C; Jeong, Jong-Hyeon; Geyer, Charles E; Rastogi, Priya; Fehrenbacher, Louis; Graham, Mark L; Chia, Stephen K; Brufsky, Adam M; Walshe, Janice M; Soori, Gamini S; Dakhil, Shaker R; Seay, Thomas E; Wade, James L; McCarron, Edward C; Paik, Soo...
Journal:
Lancet oncology
Issue:
Volume 20:Issue 1(2019)
Page Start:
88
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Validation of the NSABP/NRG Oncology 8-Gene Trastuzumab-benefit Signature in Alliance/NCCTG N9831. Issue 5 (7th September 2020)

Authors:
Pogue-Geile, Katherine L; Song, Nan; Serie, Daniel J; Wang, Ying; Gavin, Patrick G; Kim, Rim S; Tanaka, Noriko; Fumagalli, Debora; Taniyama, Yusuke; Li, Zhuo; Rastogi, Priya; Swain, Sandra M; Mamounas, Eleftherios P; Geyer, Charles E; Wolmark, Norman; Lucas, Peter C; Paik, Soonmyung; Thompson, E ...
Journal:
JNCI cancer spectrum
Issue:
Volume 4:Issue 5(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗